Training program for cancer researchers focused on hematology and oncology
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
This program is all about helping new researchers and doctors learn how to turn lab discoveries into better treatments for cancer patients, so they can provide the best care possible.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10647668 on NIH RePORTER |
What this research studies
This program aims to train postdoctoral researchers and clinical fellows in the field of hematology and oncology, emphasizing the translation of basic research into patient care. Participants will receive formal instruction and hands-on experience in various departments, including Internal Medicine and Cancer Biology, to enhance their skills in cancer research. The program is designed to address gaps in existing training and to build on the strengths of the University of Cincinnati's research initiatives. By fostering a new generation of cancer researchers, the program seeks to improve the application of scientific discoveries to clinical practice.
Who could benefit from this research
Good fit: Ideal candidates for this program are individuals pursuing advanced degrees in medicine or research who are interested in specializing in hematology and oncology.
Not a fit: Patients who are not pursuing a career in research or medicine may not directly benefit from this training program.
Why it matters
Potential benefit: If successful, this training program could lead to advancements in cancer treatment and care through the development of highly skilled researchers.
How similar studies have performed: Similar training programs have successfully produced skilled researchers who have contributed to advancements in cancer treatment, indicating a strong potential for success in this initiative.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Scaglioni, Pier Paolo — University of Cincinnati
- Study coordinator: Scaglioni, Pier Paolo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.